Why the study?
While LV-GLS by CMR-FT provides incremental prognostic value in non-ischemic dilated cardiomyopathy, less was known about the prognostic impact of right ventricular GLS.
Does right ventricular global longitudinal strain (RV-GLS) by CMR-FT improve prognostic accuracy for major cardiac events in patients with non-ischemic dilated cardiomyopathy?
Does right ventricular global longitudinal strain (RV-GLS) by CMR-FT improve prognostic accuracy for major cardiac events in patients with non-ischemic dilated cardiomyopathy?
In patients with non-ischemic dilated cardiomyopathy, assessing right ventricular global longitudinal strain by cardiac MRI significantly improves the prediction of major cardiac events beyond standard parameters like late gadolinium enhancement.
Answers are grounded in this paper and cite their sources.
RV-GLS may enhance MACE prediction beyond LGE in non-ischemic dilated cardiomyopathy; hypothesis-generating and requires prospective validation.
Aims: Left ventricular global longitudinal strain (GLS) by cardiac magnetic resonance feature tracking (CMR-FT) analysis has shown an incremental prognostic value compared to classical parameters in non-ischemic dilated cardiomyopathy (NICM). However, less is known about the role of right ventricular (RV) GLS. Our objective was to evaluate the prognostic impact of RV-GLS by CMR-FT analysis in a population of NICM patients. Methods: In this multicenter study, we examined NICM patients evaluated with a comprehensive CMR-FT study. Major cardiac events (MACEs) were considered as the study primary outcome measure and were defined as a composite of (a) cardiovascular death, (b) cardiac transplant or destination therapy ventricular assist device, (c) hospitalization for life-threatening ventricular arrhythmias or implantable cardiac defibrillator appropriate intervention. Heart failure (HF) related events, including hospitalizations and life-threatening arrhythmia-related events were considered as secondary end-points. Receiver operating time-dependent analysis were used to calculate the possible additional effect of RV-GLS to standard evaluation. Results: We consecutively enrolled 273 patients. During a median follow-up of 39 months, 41 patients (15%) experienced MACEs. RV-GLS and LV late gadolinium emerged as the strongest prognostic CMR-FT variables: their association provided an estimated 3-year MACEs rate of 29%. The addition of RV-GLS significantly improved the prognostic accuracy in predicting MACEs with respect to the standard evaluation including LGE (areas under the curve from 0.71 [0.66–0.82] to 0.76 [0.66–0.86], p = 0.03). On competing risk analysis, RV-GLS showed a significant ability to reclassify overall both HF-related and life-threatening arrhythmia-related events, regardless of LV and RV ejection fraction. Conclusions: In NICM patients, RV-GLS showed a significant prognostic role in reclassifying the risk of MACEs, incremental with respect to standard evaluation with standard prognostic parameters.
No takes yet. Share an insight, caveat, or question.
Cittar et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: